Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.
Jaká je dnes cena akcie společnosti Beximco Pharmaceuticals Limited?▼
Aktuální cena akcie R2WA.F je €0,40 EUR — za posledních 24 hodin klesla o -2,44%. Vývoj ceny akcie společnosti Beximco Pharmaceuticals Limited můžete podrobněji sledovat v grafu.
Jaký ticker má akcie společnosti Beximco Pharmaceuticals Limited?▼
Ticker akcie se může lišit podle burzy. Například na burze Frankfurt Exchange se akcie společnosti Beximco Pharmaceuticals Limited obchodují pod tickerem R2WA.F.
Jaké byly tržby společnosti Beximco Pharmaceuticals Limited za minulý rok?▼
Tržby společnosti Beximco Pharmaceuticals Limited za poslední rok činí 41,02B EUR.
Jaký je čistý zisk společnosti Beximco Pharmaceuticals Limited za minulý rok?▼